NorA Efflux Pump Inhibitors: Expanding SAR Knowledge of Pyrazolo[4,3-c][1,2]benzothiazine 5,5-Dioxide Derivatives

Giada Cernicchi1, Alessandra Di Gregorio2, Tommaso Felicetti1

  • 1Department of Pharmaceutical Sciences, Università degli Studi di Perugia, Perugia, Italy.

PubMed

Insights

This study identifies new pyrazolobenzothiazine compounds that inhibit Staphylococcus aureus NorA efflux pumps, potentially overcoming antibiotic resistance. These inhibitors, when combined with ciprofloxacin, reduce bacterial biofilm formation.

Area of Science:

  • Microbiology
  • Medicinal Chemistry
  • Pharmacology

Background:

  • Antimicrobial resistance (AMR) is a growing global health threat.
  • Microbial efflux pumps (EPs) are key mechanisms driving AMR by expelling antibiotics.
  • The Staphylococcus aureus NorA efflux pump contributes significantly to antibiotic resistance.

Purpose of the Study:

  • To discover novel molecular classes inhibiting the Staphylococcus aureus NorA efflux pump.
  • To explore the structure-activity relationship of pyrazolobenzothiazine derivatives as NorA efflux pump inhibitors (EPIs).

Main Methods:

  • Medicinal chemistry efforts involving design and synthesis of pyrazolobenzothiazine analogues.
  • Ethidium bromide efflux inhibition assays to identify NorA EPIs.
  • Synergistic assays with ciprofloxacin (CPX) against resistant bacterial strains.
  • Evaluation in NorA-overexpressing and NorA-knockout strains.

Main Results:

  • Identified three potent NorA EPIs (compounds 3, 10, and 19) from pyrazolobenzothiazine derivatives.
  • Confirmed synergy between novel EPIs and ciprofloxacin is NorA-dependent.
  • Demonstrated that combinations of NorA EPIs and ciprofloxacin reduce biofilm production in resistant strains.

Conclusions:

  • Novel pyrazolobenzothiazine derivatives show promise as NorA efflux pump inhibitors.
  • Ethidium bromide efflux assays are effective for rapid identification of NorA inhibitors.
  • Combined therapy with NorA EPIs and ciprofloxacin may offer a strategy to combat AMR and reduce biofilm formation.

Related Concept Videos

Structure-Activity Relationships and Drug Design01:28

Structure-Activity Relationships and Drug Design

Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
474
Adrenergic Agonists: Chemistry and Structure-Activity Relationship01:16

Adrenergic Agonists: Chemistry and Structure-Activity Relationship

Adrenergic agonists' structure-activity relationship (SAR) determines their selectivity and efficacy. These agonists comprise a phenylethylamine moiety with an aromatic ring and an ethylamine side chain.
Aromatic ring substitutions: Substituting the aromatic ring with –OH groups at positions 3 and 4 yields catecholamines (e.g., epinephrine), which have a high affinity for adrenoceptors. Hydrogen bonding between –OH groups and receptors enhances adrenergic activity.
Separation of...
2.5K
Carrier-Mediated Transport01:06

Carrier-Mediated Transport

Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
228
Pore Transport and Ion-Pair Transport01:17

Pore Transport and Ion-Pair Transport

Pore transport and ion-pair formation are critical mechanisms for the absorption and distribution of drugs in the body.
Pore transport, also known as convective transport, is a process where small molecules like urea, water, and sugars rapidly cross cell membranes as though there were channels or pores in the membrane. Although direct microscopic evidence is limited  but the concept of pores or channels is widely accepted based on physiological evidence. Despite the lack of direct...
324
ABC Transporters: Exporter01:31

ABC Transporters: Exporter

ATP-binding cassette or ABC transporter is the largest superfamily of integral membrane proteins. The transporters have transmembrane-binding domains (TMDs) and nucleotide-binding domains (NBDs). The TMDs are specific to their substrates, whereas the NBDs are similar to engines that complete ATP hydrolysis to complete the substrate transport. They can be full transporters consisting of two TMDs and NBDs, half transporters with one TMD and NBD, while some encoded with a single TMD or NBD are...
4.1K
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
6.7K